Astellas Pharma Ltd. today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization for PADCEVâ„¢ (enfortumab vedotin, an antibody-drug conjugate [ADC]) in ...
Some results have been hidden because they may be inaccessible to you